B

Broncus Holding Corp
HKEX:2216

Watchlist Manager
Broncus Holding Corp
HKEX:2216
Watchlist
Price: 2.69 HKD Market Closed
Market Cap: 1.4B HKD

Operating Margin
Broncus Holding Corp

-274.4%
Current
-312%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-274.4%
=
Operating Profit
-22.3m
/
Revenue
8.1m

Operating Margin Across Competitors

Broncus Holding Corp
Glance View

Market Cap
1.4B HKD
Industry
Health Care

Broncus Holding Corp. engages in provision of interventional diagnosis and therapeutics solutions. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-09-24. The firm's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.

Intrinsic Value
1.71 HKD
Overvaluation 36%
Intrinsic Value
Price
B
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-274.4%
=
Operating Profit
-22.3m
/
Revenue
8.1m
What is the Operating Margin of Broncus Holding Corp?

Based on Broncus Holding Corp's most recent financial statements, the company has Operating Margin of -274.4%.

Back to Top